Esperion Therapeutics
Gina S. Rafla is a seasoned professional in the field of pharmacovigilance, currently serving as the Senior Manager for Aggregate Reports in Global Drug Safety & Pharmacovigilance at Esperion since May 2022. Previous experience includes a role as Pharmacovigilance Manager at Glenmark Pharmaceuticals from January 2017 to April 2022, and a decade-long tenure at CVS Caremark Corporation as a pharmacist from March 2007 to December 2017. Earlier career positions include Graduate Pharmacist at Rite Aid and a Pharmacy Intern at The University of Pittsburgh Medical Center. Gina obtained a Bachelor of Pharmacy (B.Pharm.) degree in Pharmaceutical Sciences from Alexandria University, where education took place from 1998 to 2002.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.